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Clinic
St. Cloud Hospital
Patient Transfer Line
(888) 387-2862
Acute Myocardial Infarction
(877) STEMI-SC or (877) 783-6472
Adult Critical Care Intensivists
(320) 309-8132
Behavioral Health Access Nurse
(320) 255-5774
Hospitalist Program (320) 290-8933

CentraCare Clinic Specialties
Allergy (320) 654-3650
Cardiology & Cardiac Surgery
(320) 656-7020
Dermatology (320) 229-4924
Endocrinology (320) 229-5000
Gastroenterology (320) 229-4915
Genetic Services (320) 654-3654
Infectious Disease (320) 240-2204
Internal Medicine (320) 240-2203
or (320) 229-4928
Neonatology (320) 255-5781
Nephrology (320) 240-2206
Neurology (320) 240-2829
Neurosurgery (320) 229-5009
Obstetrics & Gynecology
(320) 654-3630
Oncology/Hematology
(320) 229-4907
Pediatric Critical Care (320) 255-5781
Pediatrics (320) 654-3610
Pulmonology (320) 240-2207
Radiation Oncology (320) 229-4901
Rheumatology (320) 240-2208
Sleep Medicine (320) 251-0726
Sports Medicine (320) 229-4917
Surgery (320) 252-3342
Wound Care (320) 656-7100

Physician Referral Line
(320) 240-2201
(800) 458-7272
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President’s Message

Together we can
By Allen Horn, MD, MBA, FACPE
President, CentraCare Clinic
As one strategy for responding to health care reform, the concept
of aligning incentives has received a lot of discussion and serious
evaluation in many health care organizations. Some organizations
already have shifted some physician compensation away from strict
productivity, typically measured with wRVUs, to a compensation model
with greater emphasis on quality, patient satisfaction and cost of care.
There undoubtedly will be significant changes in physician compensation
models as payment models from Medicare, Medicaid and other payers
increasingly base some payments on quality, service and value.
However, simply throwing money at providers will not be effective in
leading to the changes that will be required by the coming perfect storm
of health care reform, the economic environment, state and federal
deficits and an aging population. In an uncertain future, we all have
a choice to make. We simply can react as victims and complain about
everything we perceive is being done to us, or we can utilize the
immense talents of each other and our staff to collaboratively work
together to learn how to do more for our patients with less: provide
more quality, more service and more value, while being paid less.
Financial incentives can help reward the work needed to meet these
challenges. But, regardless of the money, we still will need to learn
how to better address the fear and anxiety of patients and how to better
motivate patients to actively participate in taking care of their health.
We still need to learn how to refocus on purpose and the meaningful
work we do, how to best appeal to the professional pride of providers
and how to motivate them to truly be patient-centered — to overcome
power struggles, turf battles, conflicting values and social mores —
so that together we can do more with less.

Noncompliant
medication use is
a significant health
care problem
By David Tilstra, MD,
Medical Director,
CentraCare Clinic
Many patients fail to take their medications as directed,
and 33 percent of patients never fill their prescriptions —
including up to 50-60 percent of patients with chronic
conditions. Improper medication use is one of the leading
causes of hospitalizations and up to 125,000 patient
deaths are linked to drug noncompliance. Improper use
of warfarin, other anticoagulants, insulin and other diabetic
drugs is a leading cause of hospital readmissions. Simply stated,
noncompliance medication use is one of the most significant
problems in health care today. Often patients are blamed
for this noncompliance, but there are things that providers
can do to help their patients.
• Assess the likelihood that the patient will be noncompliant.
There are validated tools to explore this such as the
Morisky medication adherence questionnaire, an eight-item
questionnaire that explores patient’s beliefs about taking
medications. (Available at http://www.acpinternist.org/
archives/2009/02/adherence.pdf)
• When a new drug is prescribed, always explain the
medication’s purpose, probable side effects, as well as
frequency and dosing. Ask the patient to “teach back,”
that is, tell you how they think they are supposed to take
the medication. At follow-up visits, ask how the patient
takes the medication, especially if the drug does not
appear to have the expected effect.
• Stress the effects of failing to take the medication, and
especially try to find out what drives the patient. Point out
how failure to take the medication may interfere with
some of their life plans, such as being around to see their
grandchildren.
• Try to minimize any financial barriers for the patients,
especially co-pays and other out-of-pocket costs, through
the use of generic medications. Studies have shown that
each $10 increase in co-pays is associated with a
10 percent decrease in compliance.
• Use reminder systems, from simple pill boxes to more
sophisticated automated reminder systems. Patients can
sign up for a daily text reminder to take their medications
at scriptyourfuture.org, a collaboration of the National
Consumers League and the AMA.
• Use other professionals, such as diabetes educators or
asthma educators, to teach patients about their conditions
and medication use.
(Adapted from AMA news Oct 10, 2011)

ICD-10 new documentation
requirements
By Connie Goulet, CPC, Paula Lijewski, CPC,
Sue Stein, CPC, Compliance Specialists,
CentraCare Clinic
The ICD-9 documentation guidelines today are
very specific, but they are not specific enough for
changing documentation requirements. ICD-10 is
a clinical classification system that is sophisticated
enough, and specific enough, to keep up with the
changes in medical regulations.
The “buzz” word for ICD-10 documentation is
DETAIL. Complete and detailed documentation
helps physicians organize observations and
examinations, justify their treatment plan, support
the diagnosis and document patients’ progress and
outcomes. It establishes medical necessity.
Increased clinical documentation may be required
for ICD-10 to support the specificity needed for
encounters. Additional documentation will depend
on the type of patient encounters. You will not
have to write a two-page patient visit note for
each patient encounter.
For example, if your patient comes into the office
with a sore throat and you do a simple exam,
palpate the throat, have the nursing staff perform a
strep swab, which turns out positive, and diagnose
the patient with strep throat, your regular
documentation will suffice. This is because there
are not many more specific details needed in order
to determine that the patient actually has strep throat.
Documentation variables may include:
• Type of encounter (initial or subsequent)
• Applied specificity (did the patient lose
consciousness?)
• Acute versus chronic
• Relief or non-relief (intractable versus
non-intractable)
• External cause (what caused the accident?)
• Activity (what was the patient doing when
she was injured?)
• Location (where was the patient when she
was injured?)
In conclusion, complete, accurate and detailed
documentation will be necessary to assign the
appropriate ICD-10 code, just as it is for ICD-9.

Improving asthma care in Central Minnesota
By Mary Keating, MD, Pediatric Allergist, CentraCare Clinic
More than 22 million Americans have asthma with nearly
4,000 people dying each year from complications. In
Minnesota, almost 8 percent of adults and 7 percent of
children are living with asthma. The MN Community
Measurement (MNCM) for asthma has been implemented
in Central Minnesota for our asthmatic patients with the
goal of improving asthma and achieving optimal asthma
care. Optimal asthma care for patients is defined as:
• patient has a current asthma action plan (AAP);
• asthma is well controlled as measured by the
asthma control test (ACT); and
• patient is not at increased risk of exacerbations.
The asthma action plan outlines in writing what steps
to take in the event of an asthma exacerbation. It includes
the patient’s triggers and symptoms and information
about asthma medications. The National Asthma Education
and Prevention Program strongly recommends that all
asthmatics develop their own specific action plan in
partnership with their physician. We believe the action
plan promotes asthma education.
The asthma control test is used to identify patients with
poorly controlled asthma. It also is useful for predicting an
asthma exacerbation and changes in treatment decisions.

The last MNCM measurement is determining
asthma risk. This involves asking the
patient if there have been any asthma-related
hospitalizations or emergency room visits.
The following data from September 2010 to
November 2011 demonstrates the change CentraCare Clinic
has documented for patients with asthma.

Patients with AAPs
Patients ACT done
Risk documented
Optimal asthma care

Sept. 2010
32%
34%
28%
16%

Nov. 2011
72%
84%
77%
52%

CentraCare Clinic has been working hard to improve
asthma care and is making progress with our asthma
patients. We anticipate our improvements in asthma care
will reduce emergency room visits, hospitalizations and
medical costs. If you would like to learn more about
our efforts to improve asthma care or if you have
challenges with an asthma patient, please call our
Allergy Clinic at (320) 654-3650.

Education is key to reducing carbon monoxide
poisoning in children
By Marla Moore, MD, Pediatric Critical Care, CentraCare Clinic
Epidemiology: Accidental carbon monoxide (CO) poisoning
causes an estimated 500 deaths per year in the U.S. Most
poisonings from this odorless, tasteless gas are secondary
to exposure to engine, furnace or heater exhaust.
Pathophysiology: Following inhalation, CO binds to
hemoglobin to form carboxyhemoglobin at a rate 200-300
times that of adult hemoglobin. As the hemoglobin tetramer
structure changes, oxygen release becomes more difficult,
shifting the oxygen dissociation curve to the left. CO also
interferes with cytochrome oxidase and the electron
transport chain, reducing ATP production and slowing or
shutting down cellular metabolism. Tachypnea, tachycardia,
neurologic changes, metabolic acidosis and eventual
cerebral edema and death ensue.
CO has an even greater affinity for fetal hemoglobin than
adult hemoglobin. In utero, exposure to CO can be quickly
lethal. Infants and children have higher metabolic rates than
adults, using oxygen faster and making them more
vulnerable to carbon monoxide’s toxic effects.

Testing: Blood levels greater than 20 percent
are considered mild intoxication. Levels
greater than 60 percent represent severe
intoxication. Death is likely without prompt
intervention. Blood levels may not correlate with clinical
findings. Pulse oximetry values are falsely elevated and
misleading. Every exposure should be treated promptly.
Treatment requires prompt removal from the CO source
and administration of 100 percent oxygen. If neurologic
findings warrant, endotracheal intubation may be required.
High concentrations of oxygen shorten the half life of CO
and hasten its removal from cytochrome oxidase.
Hyperbaric oxygen produces dramatic changes, shortening
the half life to as little as 30 minutes. Hyperbaric oxygen
consultation is recommended for children with persistent
neurological changes after oxygen administration.
Preventive measures: State law requires at least one CO
detector in every home. Cost is $20-$60. Remind your patients,
family and friends about this important safety measure.
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Minimally invasive surgery for lung cancer
By Scott Houghton, MD, and Matthew Maunu, MD, General Surgeons
CentraCare Clinic – River Campus
Video Assisted Thoracic Surgery (VATS) or thoracoscopy is
a minimally invasive approach to chest surgery. It is similar
to laparoscopic surgery using many of the same instruments
and techniques. Thoracoscopy has been used for simple
procedures throughout the years including wedge biopsies
and procedures for the pleural space, but now can be used to
perform more complex anatomic resections, specifically
those for lung cancer.
Lobectomy is considered the standard of care for those
patients with peripheral lung cancers that can medically
tolerate a major resection. Lobectomy for lung cancer now
can be performed thoracoscopically using three to seven
ports placed at various points in the chest. A small access
incision is used to remove the specimen and also can be
used to facilitate lung dissection.
Thoracoscopic (VATS) lobectomy has been shown to have
all of the benefits of open lobectomy for lung cancer but
avoids some of the complications. Importantly, thoracoscopic
lobectomy has been shown in prospective randomized trials
to be oncologically equivalent to open lobectomy, providing
equivalent rates of long-term survival and locoregional
recurrence. In single institution series comparing

thoracoscopic lobectomy versus thoracotomy
and lobectomy, mortality rates tend to be
lower for thoracoscopic lobectomy, but these
are not statistically significant. Blood loss
also has been shown to be similar. Length of
hospital stay, days with a chest tube and the
rate of major postoperative complications are
all lower for thoracoscopic lobectomy.
Thoracoscopic lobectomy results in decreased
postoperative pain both acutely and
chronically. Patients have fewer pulmonary
complications and are earlier to ambulate.
In our experience, many patients go home
without narcotics and those who do have
stopped them before scheduled follow-up.
Operative times are longer for thoracoscopic lobectomy,
but the benefits justify the time. Reported conversion
rates are between 2.5 and 17 percent. At our hospital,
operative times are 1.5 times longer with a conversion
rate of 10 percent.
For more information or to make a referral, contact the
CentraCare Clinic Surgery Department at (320) 240-7822.

